These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33459546)

  • 1. [Correlations between thrombodynamic parameters of coagulation and negative syndromes in patients with schizophrenia].
    Brusov OS; Oleichik IV; Karpova NS; Faktor MI; Sizov SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):86-91. PubMed ID: 33459546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombodynamic parameters of hypercoagulability in patients with affective disorder and schizophrenia in a state of exacerbation].
    Brusov OS; Oleichik IV; Faktor MI; Karpova NS; Sizov SV; Yunilaynen OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):53-57. PubMed ID: 30499497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of plasma procoagulant activity in patients with schizophrenia during pharmacotherapy: thrombodynamic parameters of coagulation before and after treatment].
    Brusov OS; Karpova NS; Faktor MI; Sizov SV; Oleichik IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):51-55. PubMed ID: 31793543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombodynamic parameters of hypercoagulation of blood in children with childhood autism and schizophrenia].
    Brusov OS; Simashkova NV; Karpova NS; Faktor MI; Nikitina SG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):59-63. PubMed ID: 30778032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The decrease in procoagulant activity of blood during combined therapy with antidepressants and antipsychotics in patients with endogenous mental disorders].
    Brusov OS; Karpova NS; Oleichik IV; Faktor MI; Sizov SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):55-60. PubMed ID: 34932286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombodynamic correlates of catatonia severity in children with autism].
    Brusov OS; Simashkova NV; Karpova NS; Faktor MI; Nikitina SG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12):57-61. PubMed ID: 31994515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of machine learning for predicting the outcome of treatment of patients with schizophrenia according to the indicators of «Thrombodynamics» test].
    Brusov OS; Senko OV; Kodryan MS; Kuznetsova AV; Matveev IA; Oleichik IV; Karpova NS; Faktor MI; Aleshenko AV; Sizov SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):45-53. PubMed ID: 34481435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paired and partial correlations of immune parameters of neuro-immuno-test and coagulation parameters of thrombodynamics test in children with children's autism].
    Brusov OS; Klyushnik TP; Zozulya SA; Karpova NS; Shilov YE; Nikitina SG; Simashkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9. Vyp. 2):68-73. PubMed ID: 36170102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A combined marker of catatonia severity including autoimmune and thrombodynamic parameters in patients with autism spectrum disorder].
    Brusov OS; Klyushnik TP; Simashkova NV; Karpova NS; Faktor MI; Zozulya SA; Nikitina SG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7):86-93. PubMed ID: 32790981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.
    Lobastov K; Dementieva G; Soshitova N; Bargandzhiya A; Barinov V; Laberko L; Rodoman G
    J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):31-41. PubMed ID: 31495765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of hemostasis disorders using the thrombodynamic test in patients with chronic glomerulonephritis with nephrotic syndrome].
    Berns AS; Sovetnikov EN; Chebotareva NV; Berns SA; Solonkina AD; Guliaev SV; Kraeva VV; Moiseev SV
    Ter Arkh; 2022 Aug; 94(6):738-742. PubMed ID: 36286850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF; de Resende CB; Abreu MN; Rocha FL; Teixeira AL; Keefe RS; Salgado JV
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis.
    Khan A; Lindenmayer JP; Opler M; Yavorsky C; Rothman B; Lucic L
    Schizophr Res; 2013 Oct; 150(1):185-96. PubMed ID: 23911252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Piecewise linear regression model of hemostasis dynamics in donors and patients with schizophrenia].
    Senko OV; Brusov OS; Ponomareva LI; Matveev IA; Karpova NS; Kuznetsova AV; Salmanov MY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):111-115. PubMed ID: 36719126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure.
    Shafer A; Dazzi F
    J Psychiatr Res; 2019 Aug; 115():113-120. PubMed ID: 31128501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between symptoms rated with the Positive and Negative Syndrome Scale and brain measures in schizophrenia.
    d'Amato T; Rochet T; Dalery J; Laurent A; Chauchat JH; Terra JL; Marie-Cardine M
    Psychiatry Res; 1992 Oct; 44(1):55-62. PubMed ID: 1461947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PO-22 - Thrombodynamics test for analysis of hemostasis in patients with malignant tumors and predicting thrombotic complications.
    Vasilenko I; Vlasova E; Metelin V; Balkanov A; Bichenkov O
    Thromb Res; 2016 Apr; 140 Suppl 1():S184. PubMed ID: 27161711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathological dimensions in schizophrenia.
    Cuesta MJ; Peralta V
    Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors.
    Fleischhacker W; Galderisi S; Laszlovszky I; Szatmári B; Barabássy Á; Acsai K; Szalai E; Harsányi J; Earley W; Patel M; Németh G
    Eur Psychiatry; 2019 May; 58():1-9. PubMed ID: 30738380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.